Mohammad Breakeit

Feasibility study of chemotherapeutic efficacy assessment in hyperthermic intraperitoneal chemotherapy (HIPEC)

Ahmed H. Mekkawy, Md Khalilur Rahman, Mohammad Breakeit, Krishna Pillai et autres

Abstract Purpose CRS-HIPEC serves as the primary treatment for peritoneal cancers. Although CRS-HIPEC frequently yields positive outcomes, some patients may experience a swift recurrence of cancer. Consequently, a technique to detect any remaining viable tumor cells post-treatment would be advantageous. We propose …

au, nl (code pays fourni par la source)

Comparison Of carcinoembryonic antigen levels between Portal and PERipheral blood in patients with appendiceal adenocarcinoma (COPPER) trial

Adam Thomas Cristaudo, David Lawson Morris, Mohammad Breakeit

In 1987, Tabuchi et al.1 conducted a study to investigate the drainage of carcinoembryonic antigen (CEA) in colorectal cancer, which suggested that CEA is released into the portal blood from primary colonic cancer lesions. Recently, the role of CEA in promoting liver …

au (code pays fourni par la source)

Novel Use of Intravesical Bromelain and N-acetylcysteine for Pseudomyxoma Peritonei with Bladder Involvement: Case Series

J Vo, Rayan Mourad, Mohammad Breakeit, Sarah J. Valle et autres

Introduction: Pseudomyxoma peritonei (PMP) is a rare and challenging neoplastic condition associated with great morbidity when left untreated.The standard treatment is cytoreductive surgery and heated intraperitoneal chemotherapy (HIPEC).However, not all patients are suitable candidates for extensive operative management, necessitating alternative avenues to …

au (code pays fourni par la source)

Intraperitoneal BromAc® Does Not Interfere with the Healing of Colon Anastomosis

Ahmed H. Mekkawy, Mohammad Breakeit, Krishna Prasad Gopalakrishna Pillai, Samina Badar et autres

A combination of bromelain and acetylcysteine, BromAc®, is an efficient intraperitoneal mucolytic for thick mucus secreted in pseudomyxoma peritonei (PMP). Patients with PMP quite often undergo colon anastomosis. Hence, we investigated the effect of the intraperitoneal delivery of BromAc® on colon-anastomosis healing …

au (code pays fourni par la source)

The Use of Intraoperative Radiation Therapy (IORT) in Multimodality Management of Cancer Patients: a Single Institution Experience

Ahmed Elashwah, Abdullah Abdulrahman Alsuhaibani, Ali A. Al‐Zahrani, Ayman Zaki Azzam et autres

Égypte, sa (code pays fourni par la source)

Second-look Surgery for Appendiceal High Grade and Colorectal Cancers Following Cytoreductive Surgery (CRS) and Hyperthermic Intraperitoneal Chemotherapy (HIPEC)

Mohammad Breakeit, DANIEL LIU, ADRIAN CHENG, Hyerim Suh et autres

BACKGROUND/AIM: Up to a third of patients undergoing cytoreductive surgery (CRS) and hyperthermic intraperitoneal chemotherapy (HIPEC) for peritoneal carcinomatosis (PC) of appendiceal or colorectal origin receive a stoma during primary surgery. Stoma reversal provides an opportunity for second-look surgery. PATIENTS AND METHODS: …

au, sa (code pays fourni par la source)

The Use of Intraoperative Radiation Therapy (IORT) in Multimodality Management of Cancer Patients. A Single Institution Experience.

Ahmed Elashwah, Abdullah Abdulrahman Alsuhaibani, Ayman Zaki Azzam, Belal Moftah et autres

Abstract Background Intraoperative radiation therapy (IORT) is a highly conformal technique given in the operating room in many cancer sites for better tumor local control by increasing the tumor radiation dose without exceeding normal tissues tolerance doses.Purpose Assess the feasibility of Intra …

Égypte, sa (code pays fourni par la source)

The impact of variation in access to care on the management of Hirschsprung disease

Ayman Al‐Jazaeri, Saud N. Al-Shanafey, Mohammed F. Zamakhshary, Wafa Al-Jarbou et autres

sa (code pays fourni par la source)